1336 related articles for article (PubMed ID: 29493058)
41. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
[TBL] [Abstract][Full Text] [Related]
42. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH
J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053
[TBL] [Abstract][Full Text] [Related]
43. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
[TBL] [Abstract][Full Text] [Related]
44. Predictors and outcomes of heart failure with mid-range ejection fraction.
Bhambhani V; Kizer JR; Lima JAC; van der Harst P; Bahrami H; Nayor M; de Filippi CR; Enserro D; Blaha MJ; Cushman M; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Brouwers FP; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Levy D; Herrington DM; van Gilst WH; Bertoni AG; Larson MG; de Boer RA; Gottdiener JS; Shah SJ; Ho JE
Eur J Heart Fail; 2018 Apr; 20(4):651-659. PubMed ID: 29226491
[TBL] [Abstract][Full Text] [Related]
45. Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry.
Kitagawa T; Hidaka T; Watanabe N; Naka M; Yamaguchi M; Kanai K; Isobe M; Kihara Y; Nakano Y;
Heart Vessels; 2022 May; 37(5):745-754. PubMed ID: 34731295
[TBL] [Abstract][Full Text] [Related]
46. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry.
Hao C; Luo J; Liu B; Xu W; Li Z; Gong M; Qin X; Shi B; Wei Y
Clin Interv Aging; 2022; 17():479-493. PubMed ID: 35444413
[TBL] [Abstract][Full Text] [Related]
48. Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure.
Huusko J; Tuominen S; Studer R; Corda S; Proudfoot C; Lassenius M; Ukkonen H
ESC Heart Fail; 2020 Oct; 7(5):2406-2417. PubMed ID: 32667143
[TBL] [Abstract][Full Text] [Related]
49. Sympathetic activation and outcomes in chronic heart failure: Does the neurohormonal hypothesis apply to mid-range and preserved ejection fraction patients?
Jimenez-Marrero S; Moliner P; Rodríguez-Costoya I; Enjuanes C; Alcoberro L; Yun S; Gonzalez-Costello J; Garay A; Tajes M; Calero E; Hidalgo E; Guerrero C; García-Romero E; Díez-López C; Cainzos-Achirica M; Comin-Colet J
Eur J Intern Med; 2020 Nov; 81():60-66. PubMed ID: 32718877
[TBL] [Abstract][Full Text] [Related]
50. Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction.
Straw S; Cole CA; McGinlay M; Drozd M; Slater TA; Lowry JE; Paton MF; Levelt E; Cubbon RM; Kearney MT; Witte KK; Gierula J
Clin Res Cardiol; 2023 Jan; 112(1):111-122. PubMed ID: 35781605
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
Savarese G; Jonsson Å; Hallberg AC; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2020 Jan; 298():59-65. PubMed ID: 31521440
[TBL] [Abstract][Full Text] [Related]
53. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
Maeder MT; Kaye DM
Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
[TBL] [Abstract][Full Text] [Related]
54. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
[TBL] [Abstract][Full Text] [Related]
55. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
[TBL] [Abstract][Full Text] [Related]
56. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
[TBL] [Abstract][Full Text] [Related]
57. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
[TBL] [Abstract][Full Text] [Related]
58. Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®.
Ibrahim NE; Song Y; Cannon CP; Doros G; Russo P; Ponirakis A; Alexanian C; Januzzi JL
ESC Heart Fail; 2019 Aug; 6(4):784-792. PubMed ID: 31268631
[TBL] [Abstract][Full Text] [Related]
59. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2).
Marui A; Nishiwaki N; Komiya T; Hanyu M; Tanaka S; Kimura T; Sakata R;
Am J Cardiol; 2015 Aug; 116(4):580-6. PubMed ID: 26092271
[TBL] [Abstract][Full Text] [Related]
60. Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study.
Linde C; Ekström M; Eriksson MJ; Maret E; Wallén H; Lyngå P; Wedén U; Cabrera C; Löfström U; Stenudd J; Lund LH; Persson B; Persson H; Hage C;
ESC Heart Fail; 2022 Aug; 9(4):2125-2138. PubMed ID: 35403374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
